Respiratory syncytial virus in older adults: understanding risk and preventive measures

Research Review CPD-Accredited E-Learning Module

Begin

Respiratory syncytial virus in older adults: understanding risk and preventive measures

This Research Review E-Learning Module is intended for GPs and discusses the burden of respiratory syncytial virus (RSV) in older adults, and use of the Arexvy (RSVPreF3 OA) vaccine to prevent RSV-associated lower respiratory tract disease in this population. It is based on a Research Review Expert Forum publication entitled “Respiratory syncytial virus in older adults: understanding risk and preventive measures”.


Before starting the module, please read the Research Review Expert Forum, accessed through the link below:

CLICK HERE
to access the quiz source material
Respiratory syncytial virus in older adults: understanding risk and preventive measures

The PDF through the link above can be viewed on screen, saved and printed.


This E-Learning Module covers:

  • The burden of RSV in older adults
  • Case studies of older New Zealanders with RSV infection
  • The development of a vaccine against RSV
  • Arexvy efficacy and safety clinical trial outcomes
  • Recommendations for the administration of Arexvy

Learning outcomes

After completing this module, you should have an improved understanding of how to:

  • Describe the burden of illness associated with RSV infection to your older patients 
  • Identify patients at risk of severe outcomes following RSV infection
  • Explain to patients the protection against RSV offered by Arexvy
  • Administer Arexvy in your practice

Contributing experts

Content for the Research Review Speaker Series was provided by:

Dr Hasan Bhally, Clinical Director for Infection Service at Waitemata Health and an infectious diseases specialist, and Professor Michael Woodward, Head of Dementia Research and a Senior Geriatrician at Austin Health in Melbourne, Australia.

Module questions have been developed by Dr Chris Tofield who works part time in General Practice in Tauranga, New Zealand, is involved in clinical research and is a clinical advisor to the Bay of Plenty District Health Board.

Accreditation

Research Review publications, videos and e-Learning modules have been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and have been approved for up to 2 CME credit per learning hour for Continuing Professional Development (CPD) purposes. Please CLICK HERE to download RNZCGP Dashboard.